Merus NV (MRUS)

Merus (MRUS) Stock Price & Analysis


MRUS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$12.03 - $30.81
Previous Close$17.4
Average Volume (3M)251.33K
Market Cap
Enterprise Value$805.92M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-6.1
May 08, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.87
Shares Outstanding46,317,281
10 Day Avg. Volume269,393
30 Day Avg. Volume251,334
Standard Deviation0.18
Financial Highlights & Ratios
Price to Book (P/B)3.69
Price to Sales (P/S)19.56
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-5.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue26.06
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-7.65
Price Target Upside115.95% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Merus NV’s price range in the past 12 months?
Merus NV lowest stock price was $12.03 and its highest was $30.81 in the past 12 months.
    What is Merus NV’s market cap?
    Currently, no data Available
    When is Merus NV’s upcoming earnings report date?
    Merus NV’s upcoming earnings report date is May 08, 2023 which is in 38 days.
      How were Merus NV’s earnings last quarter?
      Merus NV released its earnings results on Feb 28, 2023. The company reported -$1.83 earnings per share for the quarter, missing the consensus estimate of -$0.948 by -$0.882.
        Is Merus NV overvalued?
        According to Wall Street analysts Merus NV’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Merus NV pay dividends?
          Merus NV does not currently pay dividends.
          What is Merus NV’s EPS estimate?
          Merus NV’s EPS estimate is -$1.
            How many shares outstanding does Merus NV have?
            Merus NV has 46,317,280 shares outstanding.
              What happened to Merus NV’s price movement after its last earnings report?
              Merus NV reported an EPS of -$1.83 in its last earnings report, missing expectations of -$0.948. Following the earnings report the stock price went up 2.045%.
                Which hedge fund is a major shareholder of Merus NV?
                Among the largest hedge funds holding Merus NV’s share is Deerfield Management Company, LP. It holds Merus NV’s shares valued at 37M.


                  Merus Stock Smart Score

                  The Merus stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Merus NV

                  Merus NV is a clinical-stage immune-oncology company, which engages in the discovery and development of bi-specific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg on June 16, 2003 and is headquartered in Utrecht, Netherlands.


                  Top 5 ETFs holding MRUS

                  Market Value
                  Smart Score
                  BMO MSCI Innovation Index ETF
                  Up to five ETFs with an Outperform Smart Score that hold MRUS. The ETFs are listed according to market value of MRUS within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  LAVA Therapeutics
                  Reata Pharmaceuticals

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis